Home > Insider Trading > Filing (0001493152-23-000226)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1835022	Coya Therapeutics Inc.	COYA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1953080	Ann Lee	5850 San Felipe St., Suite 500 Houston, TX 77057		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2023-01-03	10,000	$0.00	10,000	No	4	P	Direct
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2023-01-03	6,479	$4.00	16,479	No	4	C	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	C	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Par Value $0.0001 Per Share	Warrant to Purchase Common Stock	Acquisiton	2023-01-03	5,000	$0.00	5,000	$7.50
Common Stock, Par Value $0.0001 Per Share	6% Convertible Note	Disposition	2023-01-03	0	$0.00	6,479	$4.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
9,479	2023-01-03	2025-01-03	No	4	P	Direct
6,479			No	4	C	Direct

Footnotes

Reporting Person purchased 10,000 shares of Common Stock and accompanying warrant to purchase 5,000 shares of Common Stock in the Issuer's initial public offering ("IPO") at a combined purchase price $5.00 per share and accompanying warrant.
Upon the closing of the Issuer's IPO, the Convertible Note automatically converted into shares of common stock by dividing the then-outstanding principal and interest due under the Convertible Note by $4.00, or 80% of the IPO price. The Reporting Person held a Convertible Note for $25,000 that accrued interest at 6% per annum.